Antibiotic prescribing patterns of French GPs for upper respiratory tract infections: Impact of fusafungine on rates of prescription of systemic antibiotics

American Journal of Respiratory Medicine

Volumn 2, Issue 6, 2003, Pages 491-498

  Fagnani, Francis ^a   German Fattal, Michèle ^b  

^a CEMKA EVAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTITUSSIVE AGENT; CORTICOSTEROID; FUSAFUNGINE; METICILLIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CASE CONTROL STUDY; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; DATA BASE; DRUG COST; DRUG INDICATION; DRUG USE; FEMALE; FLU LIKE SYNDROME; FRANCE; GENERAL PRACTITIONER; HEALTH CARE ORGANIZATION; HUMAN; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT SELECTION; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHINOPHARYNGITIS; SEX DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION;

EID: 0347525824     PISSN: 11756365     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256676     Document Type: Article

References (32)

1. Gonzales R, Malone DC, Maselli JH, et al. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 15: 757-62
2. Witte W. Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 1999; 44: 1-9
3. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-3
4. Guillemot D. Les antibiotiques sont-ils surconsommés? Rev Prat 1998; 48: 585-6
5. Centre de Coordination de la Lutte contre les Infections Nosocomiales de l'Interrégion Paris-Nord (CCLIN Paris-Nord). Surveillance des bactéries multirésistantes à partir du laboratoire dans les hôpitaux de linterrégion Paris-Nord (hors assistance Publique-Hôpitaux de Paris): rapport des résultats 2001. Paris: CCLIN Paris-Nord, 2002
6. Klugman KP, Goldstein F, Kohno S, et al. The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci. Clin Microbiol Infect 1997; 3 Suppl. 1: S48-60
7. Laurans G, Murbach V, Cattier B, et al. Observatoires régionaux du pneumocoque: surveillance de la sensibilité aux antibiotiques des pneumocoques isolés en situation pathogène en France en 1999 [online]. B.E.H. 2001 no. 33. Available from URL: http://www.invs.sante.fr/beh/2001/33/index.htm [Accessed 2003 Oct 13]
8. Chaix C, Durand-Zaleski I, Alberti C, et al. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999; 282: 1745-51
9. Ball P, Baquero F, Cars O, et al. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. The Consensus Group on Resistance and Prescribing In Respiratory Tract Infection. J Antimicrob Chemother 2002; 49: 31-40
10. Agence du Médicament. Antibiothérapie par voie générale en pratique courante: infections ORL et respiratoires basses. Presse Med 1999; 28: 406-14
11. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001; 134: 479-86
12. Agence Francaise de Sécurité Sanitaire des Produits de Santé (AFSSaPS). Antibiothérapie par voie generale en pratique courante: infections ORL et respiratoires basses. Ánn Otolaryngol Chir Cervicofac 1999; 116: 302-14
13. Bradley CP. Decision making and prescribing patterns: a literature review. Fam Pract 1991; 8: 276-87
14. Greenhalgh T, Gill P. Pressure to prescribe. BMJ 1997; 315: 1482-3
15. Cockburn J, Pit S. Prescribing behaviour in clinical practice: patients' expectations and doctors' perceptions of patients' expectations: a questionnaire study. BMJ 1997; 315: 520-3
16. Portier H. Résultat de l'évaluation du test de diagnostic rapide dans les angines. Abstract ORL-Pneumo-Allergo 2002; 2: 4-5
17. Guéniot C. Actualités des angines. Panorama Médecin 2001; 4824: 20
18. Caisse nationale d'assurance maladie. Mieux utiliser les antibiotiques, c'est préserver lent efficacité. Concours Med 2002; 124-23: 1614
19. Agence du Médicament. Prescription et consommation des antibiotiques en ambulatoire. Presse Med 1999; 28: 343-50
20. German-Fattal M. Fusafungine: an antimicrobial agent for the local treatment of respiratory tract infections. Clin Drug Invest 1996; 12: 308-17
21. German-Fattal M. Fusafungine, an antimicrobial with anti-inflammatory properties in respiratory tract infections. Clin Drug Invest 2001; 21: 653-70
22. Cuénant G. Value of Locabiotal® aerosol in rhinosinusitis. Rhinology Suppl 1988; 5: 69-74
23. Reinert P. Intérêt des test rapides pour la detection des infections streptococciques: illustration par une étude sur Locabiotal Pressuriseé dans les amygdalites. Maladies Médicaments 1989; 5: 113-23
24. Samolinski B, Zawisza E, Arcimowicz M, et al. Influence of fusafungine upon viral and bacterial infections. Med Sci Monit 1997; 3: 736-43
25. Bisno AL, Gerber MA, Gwaltney Jr JM, et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002; 35: 113-25
26. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med 2001; 134: 490-4
27. Hickner JM, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 34: 498-505
28. Cooper RJ, Hoffmann JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: backgrouud. Ann Intern Med 2001; 134: 509-17
29. Guillemot D, Carbon C, Vauzelle-Kervroedan F, et al. Inappropriateness and variability of antibiotic prescription among French office-based physicians. J Clin Epidemiol 1998; 51: 61-8
30. Guillemot D, Maison P, Carbon C, et al. Trends in antimicrobial drug use in the community: France, 1981-1992. J Infect Dis 1998; 177: 492-7
31. Bouvenot G. French National Institute for prescriptions and consumption of medicines: prescriptions and consumption of antibiotics for respiratory infections. Bull Acad Natl Med 1999; 183: 601-13
32. Gerber MA, Randolph MF, Chanatry J, et al. Antigen detection test for streptococcal pharyngitis: evaluation of sensitivity with respect to true infections. J Pediatr 1986; 108: 654-8